Moreover, somatic mutations, resulting in SHP2 hyperactivation, are found in a wide range of cancers, including juvenile myelomonocytic leukemias (JMML, MIM #607785) and other myeloid neoplasms [2,33,34]. The gene discussed is PTPN11; the disease is juvenile myelomonocytic leukemia.